Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Etanercept Dose Reduction in Patients With Ankylosing Spondylitis

NCT02638896 is registered in ClinicalTrials.gov with Zhixiang Huang as lead sponsor.

NCT NCT02638896
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02638896 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Etanercept Dose Reduction in Patients With Ankylosing Spondylitis
Lead sponsor
Zhixiang Huang
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2016
Completion date
April 30, 2017
Enrollment
100 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ankylosing spondylitis